SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001615774-17-000561
Filing Date
2017-02-13
Accepted
2017-02-13 16:56:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A s105324_sc13ga.htm SC 13G/A 51416
  Complete submission text file 0001615774-17-000561.txt   52824
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 17600159
SIC: 2834 Pharmaceutical Preparations